Search research articles
Contact Us
Filters
Showing results (21-30 of 34) with videos related to
Page
of 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR
Wee Loon Ong, John Nikitas, David Joseph, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 12, 2026
Phase 2 Prospective Trial of Retreatment with [<sup>177</sup>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA
John Nikitas, Adrien Holzgreve, Jesus Juarez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 28, 2025
Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of <sup>177</sup>Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol
Adrien Holzgreve, Astrid Delker, Zachary Ells, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy
John Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials
John Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 16, 2025
Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy
John Nikitas, Ting Martin Ma, Kiri Cook, et al.
JAMA Oncology
|
May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial
John Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
European Urology
|
September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium
Wee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
JAMA Network Open
|
December 17, 2025
Five-Day Preoperative Radiation Therapy for Patients With High-Risk Soft Tissue Sarcoma: A Nonrandomized Clinical Trial
John Nikitas, Joseph K Kendal, Ricky R Savjani, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 34) with videos related to
Sort By:
Page
of 4
International Journal of Radiation Oncology, Biology, Physics
|
October 6, 2023
Long-Term Quality-of-Life Outcomes After Prostate Radiation Therapy With or Without High-Dose-Rate Brachytherapy Boost: Post Hoc Analysis of TROG 03.04 RADAR
Wee Loon Ong, John Nikitas, David Joseph, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 12, 2026
Phase 2 Prospective Trial of Retreatment with [<sup>177</sup>Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer-RE-LuPSMA
John Nikitas, Adrien Holzgreve, Jesus Juarez, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 28, 2025
Randomized Phase 2 Trial of an Extended and Flexible Dosing Schedule of <sup>177</sup>Lu-PSMA Molecular Radiotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT): Study Protocol
Adrien Holzgreve, Astrid Delker, Zachary Ells, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
February 16, 2026
Five-Year Outcomes After Prostate-Specific Membrane Antigen PET/CT-Guided Salvage Radiotherapy Following Radical Prostatectomy
John Nikitas, Clayton P Smith, Wesley R Armstrong, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 27, 2023
Prostate-Specific Antigen Response to Androgen Deprivation Therapy in the Neoadjuvant Setting for High-Risk Prostate Adenocarcinoma (PIRANHA): Pooled Analysis of Two Randomized Clinical Trials
John Nikitas, Wee Loon Ong, Nathalie Carrier, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 16, 2025
Dose-escalated stereotactic body radiotherapy re-irradiation in patients with recurrent head and neck cancer: a prospective phase 2 study using automated non-coplanar volumetric modulated arc therapy
John Nikitas, Ting Martin Ma, Kiri Cook, et al.
JAMA Oncology
|
May 15, 2025
Patient-Reported Outcomes With Stereotactic Intensity Modulated Radiotherapy After Radical Prostatectomy: A Nonrandomized Clinical Trial
John Nikitas, Leslie K Ballas, Tahmineh Romero, et al.
European Urology
|
September 20, 2024
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Randomized Trials in Cancer of the Prostate (MARCAP) Consortium
Wee Loon Ong, Tahmineh Romero, Soumyajit Roy, et al.
JAMA Network Open
|
December 17, 2025
Five-Day Preoperative Radiation Therapy for Patients With High-Risk Soft Tissue Sarcoma: A Nonrandomized Clinical Trial
John Nikitas, Joseph K Kendal, Ricky R Savjani, et al.
European Urology Oncology
|
June 20, 2025
Pooled Analysis of the SOLAR and SATURN Clinical Trials Comparing Progression of Synchronous Versus Metachronous Prostate-specific Membrane Antigen-defined Oligometastatic Prostate Cancer Following Systemic and Tumor-directed Therapy
Jesus E Juarez Casillas, John Nikitas, Matthew B Rettig, et al.
Page
of 4